Analyzing how cancer evolves over time using genomic data
The MSK Genomic Data Analysis Center for Tumor Evolution
['FUNDING_OTHER'] · SLOAN-KETTERING INST CAN RESEARCH · NIH-10912743
This study is looking at how cancer changes in patients over time, especially after treatment, to help create better treatments and improve outcomes for people living with cancer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SLOAN-KETTERING INST CAN RESEARCH (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10912743 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding cancer evolution by analyzing genomic and transcriptomic data from patients. It aims to develop advanced tools and methodologies to study how cancer changes over time, particularly after treatment. By shifting the focus from just primary tumors to the dynamic changes that occur throughout a patient's clinical journey, the research seeks to uncover new insights into cancer progression and resistance to therapies. This comprehensive approach could lead to better-targeted treatments and improved patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients undergoing treatment who have had genomic sequencing performed on their tumors.
Not a fit: Patients with non-cancerous conditions or those who have not undergone genomic sequencing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments by identifying new therapeutic targets and understanding resistance mechanisms.
How similar studies have performed: Previous research has shown success in understanding cancer evolution through genomic analysis, indicating that this approach has the potential for significant breakthroughs.
Where this research is happening
NEW YORK, UNITED STATES
- SLOAN-KETTERING INST CAN RESEARCH — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SCHULTZ, NIKOLAUS — SLOAN-KETTERING INST CAN RESEARCH
- Study coordinator: SCHULTZ, NIKOLAUS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.